Cox2 Inhibition During Nephrogenic Period Induces An Angiotensin Ii Hypertension And Sex Dependent Changes In Renal Function During Ageing
Published online on December 11, 2013
Abstract
This study was performed to test the hypothesis that angiotensin II (Ang II) contributes to the hypertension and renal functional alterations induced by a decrease of COX2 activity during nephrogenic period. It was also examined whether renal functional reserve and renal response to volume overload and high sodium intake are reduced in 3-4 and 9-11 months old male and female rats treated with vehicle or a COX2 inhibitor during nephrogenic period (COX2np). Our data show that this COX2 inhibition induces an Ang II-dependent hypertension that is similar in male and female rats. Renal functional reserve is reduced in COX2np-treated rats since their renal response to an increase in plasma aminoacids levels is abolished, and their renal ability to eliminate a sodium load is impaired (P<0.05). This reduction in renal excretory ability is similar in both sexes during aging but does not induce the development of a sodium-sensitive hypertension. However, the prolonged high sodium intake at 9-11 months of age leads to a greater proteinuria in male than in female (114±12 mg/min vs. 72±8 mg/min, P<0.05) COX2np-treated rats. Renal hemodynamic sensitivity to acute increments in Ang II is unaltered in both sexes and at both ages in COX2np-treated rats. In summary, these results indicate that the reduction of COX2 activity during nephrogenic period programs for the development of an Ang II-dependent hypertension, reduces renal functional reserve to a similar extent in both sexes, and increases proteinuria in males but not in females when there is a prolonged increment in sodium intake.